Clinical Efficacy Assessment of Cefteram Pivoxil Using Clinical Scoring Systems in Children with Acute Rhinosinusitis

DOI Web Site

Bibliographic Information

Other Title
  • 小児急性鼻副鼻腔炎のスコアリングシステムによるセフテラムピボキシル（CFTM-PI）の有効性評価
  • 薬物 小児急性鼻副鼻腔炎のスコアリングシステムによるセフテラムピボキシル(CFTM-PI)の有効性評価
  • ヤクブツ ショウニ キュウセイ ビ フクビコウエン ノ スコアリング システム ニ ヨル セフテラムピボキシル(CFTM-PI)ノ ユウコウセイ ヒョウカ

Search this article

Abstract

In the present study, we assessed the efficacy of cefteram pivoxil in children with moderate or more severe acute rhinosinusitis. In addition, we evaluated the efficacy of clinical scoring systems based on clinical symptoms and the condition of the individual patient. Cefteram pivoxil administered at 18 mg/kg/day showed better efficacy and rapid onset of action. Moreover, clinical scoring systems enabled us to evaluate the condition and symptoms chronologically. This result suggested that the clinical scoring systems were useful for clinical efficacy assessment in acute pediatric rhinosinusitis.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top